<DOC>
	<DOCNO>NCT00779493</DOCNO>
	<brief_summary>Evidence exist support low-grade inflammation incite factor lead visceral hypersensitivity alteration motility irritable bowel syndrome.In medical literature , ample vitro vivo evidence support turmeric derivative curcumin antitumor , anti-inflammatory antioxidant agent . We propose randomize , placebo-controlled , double blind , parallel treatment study evaluate effect turmeric symptom irritable bowel syndrome .</brief_summary>
	<brief_title>Curcumin ( Tumeric ) Treatment Irritable Bowel Syndrome : A Randomized-Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Patients hospital clinic Southern California Permanente Medical Group conform Rome III criterion Age 18 year , Male female , Able give consent follow treatment plan able answer survey . Negative serum pregnancy test ( female childbearing potential ) willing use adequate method contraception throughout duration study . Any following : diabetes , HIV disease , use anticoagulant antiplatelet medication , abnormal coagulation thrombocytopenia , biliary obstruction , inflammatory bowel , symptomatic gallstone , celiac disease , ongoing use medication know cause exacerbate symptom IBS chronic , daily user IBS medication . Use schedule IBS medication 4 week prior treatment period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>irritable bowel syndrome</keyword>
	<keyword>constipation</keyword>
	<keyword>diarrhea</keyword>
	<keyword>gas</keyword>
	<keyword>bloating</keyword>
	<keyword>abdominal pain</keyword>
	<keyword>disturbance defecation</keyword>
	<keyword>irritable colon</keyword>
</DOC>